Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,585.00
-105.00 (-2.85%)
At close: Mar 19, 2026
KOSDAQ:142280 Market Cap
KOSDAQ:142280 has a market cap or net worth of 79.25 billion as of March 20, 2026. Its market cap has decreased by -1.33% in one year.
Market Cap
79.25B
Enterprise Value
98.34B
Revenue
108.41B
Ranking
n/a
PE Ratio
24.97
Stock Price
3,585.00
Market Cap Chart
Since December 17, 2014, KOSDAQ:142280's market cap has decreased from 98.95B to 79.25B, a decrease of -19.91%. That is a compound annual growth rate of -1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 79.25B | -8.99% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 466.26B |
| Dx & Vx | 435.05B |
| GENINUS | 201.78B |
| HLB Panagene | 117.54B |
| Cytogen | 104.62B |
| Protia | 64.19B |
| Seoulin Bioscience | 57.20B |
| GeneMatrix | 42.01B |